Page last updated: 2024-11-04

vorinostat and Peripheral Nervous System Diseases

vorinostat has been researched along with Peripheral Nervous System Diseases in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, KC1
Alsina, M1
Bensinger, W1
Biermann, JS1
Cohen, AD1
Devine, S1
Djulbegovic, B1
Faber, EA1
Gasparetto, C1
Hernandez-Illizaliturri, F1
Huff, CA1
Kassim, A1
Krishnan, AY1
Liedtke, M1
Meredith, R1
Raje, N1
Schriber, J1
Singhal, S1
Somlo, G1
Stockerl-Goldstein, K1
Treon, SP1
Weber, D1
Yahalom, J1
Yunus, F1
Shead, DA1
Kumar, R1

Other Studies

1 other study available for vorinostat and Peripheral Nervous System Diseases

ArticleYear
Multiple myeloma, version 1.2013.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2013, Jan-01, Volume: 11, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; B

2013